293
Views
11
CrossRef citations to date
0
Altmetric
Review

Influences of environmental exposures on preterm lung disease

, ORCID Icon, &
Pages 1271-1279 | Received 27 Apr 2021, Accepted 09 Jun 2021, Published online: 17 Jun 2021

References

  • Chawanpaiboon S, Vogel JP, Moller AB, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019 Jan;7(1):e37–e46.
  • Collaco JM, McGrath-Morrow SA. Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more. Ann Am Thorac Soc. 2018 May;15(5):530–538.
  • Northway WH Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368.
  • Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015 Sep 8;314(10):1039–1051.
  • Abman SH, Bancalari E, Jobe A. The evolution of bronchopulmonary dysplasia after 50 years. Am J Respir Crit Care Med. 2017 Feb 15;195(4):421–424.
  • Siffel C, Kistler KD, Lewis JFM, et al. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med. 2019;9:1–11.
  • Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162–2172.
  • McGrath-Morrow SA, Collaco JM. Bronchopulmonary dysplasia: what are its links to COPD? Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619892492.
  • Kotecha SJ, Edwards MO, Watkins WJ, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 2013 Aug;68(8):760–766.
  • Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics. 2008 Sep;122(3):479–485.
  • Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006 Jun;117(6):1901–1906.
  • Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001 Jun;163(7):1723–1729.
  • Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991 Sep 21;303(6804):671–675.
  • Chan JY, Stern DA, Guerra S, et al. Pneumonia in childhood and impaired lung function in adults: a longitudinal study. Pediatrics. 2015 Apr;135(4):607–616.
  • Milanzi EB, Gehring U. Detrimental effects of air pollution on adult lung function. Eur Respir J. 2019 Jul;54:1.
  • Brumberg HL, Karr CJ. Ambient air pollution: health hazards to children. Pediatrics. 2021 Jun;147(6):e2021051484.
  • Wagijo MA, Sheikh A, Duijts L, et al. Reducing tobacco smoking and smoke exposure to prevent preterm birth and its complications. Paediatr Respir Rev. 2017;22:3–10.
  • Gibbs K, Collaco JM, McGrath-Morrow SA. Impact of tobacco smoke and nicotine exposure on lung development. Chest. 2016 Feb;149(2):552–561.
  • Morrow LA, Wagner BD, Ingram DA, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017 Aug 1;196(3):364–374.
  • Halterman JS, Lynch KA, Conn KM, et al. Environmental exposures and respiratory morbidity among very low birth weight infants at 1 year of life. Arch Dis Child. 2009 Jan;94(1):28–32.
  • Collaco JM, Aherrera AD, Ryan T, et al. Secondhand smoke exposure in preterm infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2014 Feb;49(2):173–178.
  • Unal S, Kaya A, Bilgin L, et al. Wheezing, asthma, and atopy in premature infants at 2 years of age. Turk J Med Sci. 2017 Apr 18;47(2):607–613.
  • Palta M, Sadek-Badawi M, Sheehy M, et al. Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol. 2001 Sep 15;154(6):521–529.
  • Hennessy EM, Bracewell MA, Wood N, et al. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child. 2008 Dec;93(12):1037–1043.
  • Simpson SJ, Turkovic L, Wilson AC, et al. Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study. Lancet Child Adolesc Health. 2018 May;2(5):350–359.
  • Ortiz LE, McGrath-Morrow SA, Sterni LM, et al. Sleep disordered breathing in bronchopulmonary dysplasia. Pediatr Pulmonol. 2017 Dec;52(12):1583–1591.
  • Keller RL, Feng R, DeMauro SB, et al. Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J Pediatr. 2017;187:89–97 e3.
  • Martinez S, Garcia-Meric P, Millet V, et al. Tobacco smoke in infants with bronchopulmonary dysplasia. Eur J Pediatr. 2015 Jul;174(7):943–948.
  • Kitchen WH, Olinsky A, Doyle LW, et al. Respiratory health and lung function in 8-year-old children of very low birth weight: a cohort study. Pediatrics. 1992 Jun;89(6 Pt 2):1151–1158.
  • Groner JA, Rule AM, McGrath-Morrow SA, et al. Assessing pediatric tobacco exposure using parent report: comparison with hair nicotine. J Expo Sci Environ Epidemiol. 2018 Nov;28(6):530–537.
  • Collaco JM, Aherrera AD, Breysse PN, et al. Hair nicotine levels in children with bronchopulmonary dysplasia. Pediatrics. 2015 Mar;135(3):e678–86.
  • Ong T, Schechter MS. Is it acceptable to assess prenatal smoking risk to infants without considering socioeconomic status? Am J Respir Crit Care Med. 2018 Apr 1;197(7):965–966.
  • Singh SP, Chand HS, Langley RJ, et al. Gestational exposure to sidestream (secondhand) cigarette smoke promotes transgenerational epigenetic transmission of exacerbated allergic asthma and bronchopulmonary dysplasia. J Immunol. 2017 May 15;198(10):3815–3822.
  • Collaco JM, Morrow M, Rice JL, et al. Impact of road proximity on infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2020 Feb;55(2):369–375.
  • Schultz ES, Hallberg J, Bellander T, et al. Early-life exposure to traffic-related air pollution and lung function in adolescence. Am J Respir Crit Care Med. 2016 Jan 15;193(2):171–177.
  • Lin H, Wang X. The effects of gasotransmitters on bronchopulmonary dysplasia. Eur J Pharmacol. 2020 Apr;15(873):172983.
  • Madurga A, Golec A, Pozarska A, et al. The H2S-generating enzymes cystathionine beta-synthase and cystathionine gamma-lyase play a role in vascular development during normal lung alveolarization. Am J Physiol Lung Cell Mol Physiol. 2015 Oct 1;309(7):L710–24.
  • Rice JL, McGrath-Morrow SA, Collaco JM. Indoor air pollution sources and respiratory symptoms in bronchopulmonary dysplasia. J Pediatr. 2020 Jul;222(85–90):e2.
  • Cui X, Li Z, Teng Y, et al. Association between bedroom particulate matter filtration and changes in airway pathophysiology in children with asthma. JAMA Pediatr. 2020 Jun 1;174(6):533–542.
  • Mazza D, McGrath-Morrow SA, Collaco JM. Use and perceptions of electronic cigarettes among caregivers of infants and children with bronchopulmonary dysplasia. Pediat Aller Imm Pul. 2017 Sep;30(3):141–147.
  • Galiatsatos P, Gomez E, Lin CT, et al. Secondhand smoke from electronic cigarette resulting in hypersensitivity pneumonitis. BMJ Case Rep. 2020 Mar 22;13(3):e233381.
  • Bayly JE, Bernat D, Porter L, et al. Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma. Chest. 2019 Jan;155(1):88–93.
  • McGrath-Morrow SA, Hayashi M, Aherrera A, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PloS One. 2015;10(2):e0118344.
  • Noel A, Hansen S, Zaman A, et al. In utero exposures to electronic-cigarette aerosols impair the Wnt signaling during mouse lung development. Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1;318(4):L705–L722.
  • Swearingen C, Simpson P, Cabacungan E, et al. Social disparities negatively impact neonatal follow-up clinic attendance of premature infants discharged from the neonatal intensive care unit. J Perinatol. 2020 May;40(5):790–797.
  • Abdulla L, McGowan EC, Tucker RJ, et al. Disparities in preterm infant emergency room utilization and rehospitalization by maternal immigrant status. J Pediatr. 2020;220:27–33.
  • Vohr B, McGowan E, Keszler L, et al. Impact of a transition home program on rehospitalization rates of preterm infants. J Pediatr. 2017;181:86–92 e1.
  • Vohr B, McGowan E, Keszler L, et al. Effects of a transition home program on preterm infant emergency room visits within 90 days of discharge. J Perinatol. 2018 Feb;38(2):185–190.
  • Wai KC, Hibbs AM, Steurer MA, et al. Maternal black race and persistent wheezing illness in former extremely low gestational age newborns: secondary analysis of a randomized trial. J Pediatr. 2018;198:201–208 e3.
  • Lorch SA, Wade KC, Bakewell-Sachs S, et al. Racial differences in the use of respiratory medications in premature infants after discharge from the neonatal intensive care unit. J Pediatr. 2007 Dec;151(6):604–10, 610 e1.
  • Collaco JM, Choi SJ, Riekert KA, et al. Socio-economic factors and outcomes in chronic lung disease of prematurity. Pediatr Pulmonol. 2011 Jul;46(7):709–716.
  • Morris BH, Gard CC, Kennedy K, et al. Rehospitalization of extremely low birth weight (ELBW) infants: are there racial/ethnic disparities? J Perinatol. 2005 Oct;25(10):656–663.
  • Zheng M, Wang X, Zhang L. Association between allergic and nonallergic rhinitis and obstructive sleep apnea. Curr Opin Allergy Clin Immunol. 2018 Feb;18(1):16–25.
  • Mowitz ME, Mangili A, Han L, et al. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia. Expert Rev Pharmacoecon Outcomes Res. 2020;4:1–9.
  • Bockli K, Andrews B, Pellerite M, et al. Trends and challenges in United States neonatal intensive care units follow-up clinics. J Perinatol. 2014 Jan;34(1):71–74.
  • Morrow CB, McGrath-Morrow SA, Collaco JM. Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia. J Perinatol. 2018 Sep;38(9):1258–1265.
  • Brandon GD, Adeniyi-Jones S, Kirkby S, et al. Are outcomes and care processes for preterm neonates influenced by health insurance status? Pediatrics. 2009 Jul;124(1):122–127.
  • Lagatta J, Murthy K, Zaniletti I, et al. Home oxygen use and 1-year readmission among infants born preterm with bronchopulmonary dysplasia discharged from children’s hospital neonatal intensive care units. J Pediatr. 2020;220:40–48 e5.
  • Jackson WM, O’Shea TM, Allred EN, et al. Risk factors for chronic lung disease and asthma differ among children born extremely preterm. Pediatr Pulmonol. 2018 Nov;53(11):1533–1540.
  • McAleese KA, Knapp MA, Rhodes TT. Financial and emotional cost of bronchopulmonary dysplasia. Clin Pediatr (Phila). 1993 Jul;32(7):393–400.
  • Cristea AI, Ackerman VL, Davis SD, et al. Median household income: association with mortality in children on chronic ventilation at home secondary to bronchopulmonary dysplasia. Pediatr Allergy Immunol Pulmonol. 2015 Mar 1;28(1):41–46.
  • Kim NH, Youn YA, Cho SJ, et al. The predictors for the non-compliance to follow-up among very low birth weight infants in the Korean neonatal network. PloS One. 2018;13(10):e0204421.
  • Brady JM, Pouppirt N, Bernbaum J, et al. Why do children with severe bronchopulmonary dysplasia not attend neonatal follow-up care? Parental views of barriers. Acta paediatrica. 2018 Jun;107(6):996–1002.
  • Collaco JM, Kole AJ, Riekert KA, et al. Respiratory medication adherence in chronic lung disease of prematurity. Pediatr Pulmonol. 2012 Mar;47(3):283–291.
  • Yeh J, McGrath-Morrow SA, Collaco JM. Oxygen weaning after hospital discharge in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2016 Nov;51(11):1206–1211.
  • Frogel MP, Stewart DL, Hoopes M, et al. A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. J Manag Care Pharm. 2010 Jan-Feb;16(1):46–58.
  • Abman SH, Collaco JM, Shepherd EG, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017 Feb;181(12–28):e1.
  • Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24;132(21):2037–2099.
  • Guaman MC, Gien J, Baker CD, et al. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2015 Aug;32(10):960–967.
  • Collaco JM, Agarwal A, Austin ED, et al. Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States. Pediatr Pulmonol. 2021 Jun;56(6):1617-1625.
  • Gien J, Kinsella J, Thrasher J, et al. Retrospective analysis of an interdisciplinary ventilator care program intervention on survival of infants with ventilator-dependent bronchopulmonary dysplasia. Am J Perinatol. 2017 Jan;34(2):155–163.
  • Baker CD, Martin S, Thrasher J, et al. A standardized discharge process decreases length of stay for ventilator-dependent children. Pediatrics. 2016 Apr;137(4).
  • Vasquez P, Romero Diaz HA, Gomez Gomez MJ, et al. Bronchopulmonary dysplasia predictor scale validation in preterm newborns in two neonatal units at 2600m above sea level. Infant Behav Dev. 2018;52:1–8.
  • Fernandez CL, Fajardo CA, Favareto MV, et al. Oxygen dependency as equivalent to bronchopulmonary dysplasia at different altitudes in newborns 1500 g at birth from the SIBEN network. J Perinatol. 2014 Jul;34(7):538–542.
  • Britton JR. Altitude, oxygen and the definition of bronchopulmonary dysplasia. J Perinatol. 2012 Nov;32(11):880–885.
  • Gulliver K, Yoder BA. Bronchopulmonary dysplasia: effect of altitude correction and role for the neonatal research network prediction algorithm. J Perinatol. 2018 Aug;38(8):1046–1050.
  • Alshehri MA. Are preterm infants at high altitude at greater risk for the development of bronchopulmonary dysplasia? J Trop Pediatr. 2014 Feb;60(1):68–73.
  • Lee SK, Ye XY, Singhal N, et al. Higher altitude and risk of bronchopulmonary dysplasia among preterm infants. Am J Perinatol. 2013 Aug;30(7):601–606.
  • Radhakrishnan D, Ouedraogo A, Shariff SZ, et al. The association between climate, geography and respiratory syncitial virus hospitalizations among children in Ontario, Canada: a population-based study. BMC Infect Dis. 2020 Feb 19;20(1):157.
  • Chi H, Chung CH, Lin YJ, et al. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan. PloS One. 2018;13(5):e0197410.
  • Hsu CH, Lin CY, Chi H, et al. Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate. PloS One. 2014;9(10):e110166.
  • Mirsaeidi M, Motahari H, Taghizadeh Khamesi M, et al. Climate change and respiratory infections. Ann Am Thorac Soc. 2016 Aug;13(8):1223–1230.
  • Basray R, Malik A, Waqar W, et al. Impact of environmental factors on COVID-19 cases and mortalities in major cities of Pakistan. J Biosaf Biosecur. 2021 Jun;3(1):10–16.
  • Sanchez-Solis M, Perez-Fernandez V, Bosch-Gimenez V, et al. Lung function gain in preterm infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 2016 Sep;51(9):936–942.
  • Thurlbeck WM. Postnatal human lung growth. Thorax. 1982 Aug;37(8):564–571.
  • Wang LY, Luo HJ, Hsieh WS, et al. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants. Pediatr Pulmonol. 2010 Feb;45(2):165–173.
  • Aoyama BC, Collaco JM, McGrath-Morrow SA. Predictors of pulmonary function at 6 years of age in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2021 May;56(5):974-981.
  • Piersigilli F, Van Grambezen B, Hocq C, et al. Nutrients and microbiota in lung diseases of prematurity: the placenta-gut-lung triangle. Nutrients. 2020 Feb 13;12(2):469.
  • Huang J, Zhang L, Tang J, et al. Human milk as a protective factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Childhood Fetal Neonatal Ed. 2019 Mar;104(2):F128–F136.
  • Kim LY, McGrath-Morrow SA, Collaco JM. Impact of breast milk on respiratory outcomes in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2019 Mar;54(3):313–318.
  • Park HW, Lim G, Park YM, et al. Association between vitamin D level and bronchopulmonary dysplasia: a systematic review and meta-analysis. PloS One. 2020;15(7):e0235332.
  • Schwartz E, Zelig R, Parker A, et al. Vitamin A supplementation for the prevention of bronchopulmonary dysplasia in preterm infants: an update. Nutr Clin Pract. 2017 Jun;32(3):346–353.
  • Stone CA Jr., McEvoy CT, Aschner JL, et al. Update on vitamin E and its potential role in preventing or treating bronchopulmonary dysplasia. Neonatology. 2018;113(4):366–378.
  • Resch B, Kurath-Koller S, Eibisberger M, et al. Prematurity and the burden of influenza and respiratory syncytial virus disease. World J Pediatr. 2016 Feb;12(1):8–18.
  • Collaco JM, McGrath-Morrow SA. Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life. Pediatr Pulmonol. 2021 Mar 17. DOI: https://doi.org/10.1002/ppul.25301.
  • Yeo KT, de la Puerta R, Tee NWS, et al. Burden, etiology, and risk factors of respiratory virus infections among symptomatic preterm infants in the tropics: a retrospective single-center cohort study. Clin Infect Dis. 2018 Oct 30;67(10):1603–1609.
  • McGrath-Morrow SA, Lee G, Stewart BH, et al. Day care increases the risk of respiratory morbidity in chronic lung disease of prematurity. Pediatrics. 2010 Oct;126(4):632–637.
  • Hagen EW, Sadek-Badawi M, Palta M. Daycare attendance and risk for respiratory morbidity among young very low birth weight children. Pediatr Pulmonol. 2009 Nov;44(11):1093–1099.
  • Prais D, Kaplan E, Klinger G, et al. Short- and long-term pulmonary outcome of palivizumab in children born extremely prematurely. Chest. 2016 Mar;149(3):801–808.
  • Amitai N, Stafler P, Blau H, et al. Palivizumab following extremely premature birth does not affect pulmonary outcomes in adolescence. Chest. 2020 Aug;158(2):660–669.
  • Haque AK, Kanz MF. Asbestos bodies in children’s lungs. An association with sudden infant death syndrome and bronchopulmonary dysplasia. Arch Pathol Lab Med. 1988 May;112(5):514–518.
  • Hadchouel A, Durrmeyer X, Bouzigon E, et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2011 Nov 15;184(10):1164–1170.
  • Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics. 2013 Aug;132(2):290–297.
  • Ambalavanan N, Cotten CM, Page GP, et al. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr. 2015 Mar;166(3):531–7 e13.
  • Lewis T, Truog W, Norberg M, et al. Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids in preterm infants at risk for bronchopulmonary dysplasia. Pediatr Res. 2019 Apr;85(5):625–633.
  • Cohen J, Van Marter LJ, Sun Y, et al. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol. 2007;8(10):R210.
  • Cuna A, Halloran B, Faye-Petersen O, et al. Alterations in gene expression and DNA methylation during murine and human lung alveolar septation. Am J Respir Cell Mol Biol. 2015 Jul;53(1):60–73.
  • Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018 Jul;6(7):535–544.
  • Agusti A, Faner R. Lung function trajectories in health and disease. Lancet Respir Med. 2019 Apr;7(4):358–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.